Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 226

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Selective stimulation of T helper 2 cytokine responses by the anti‐psoriasis agent monomethylfumarate

de Jong, Rolien, Bezemer, Anja C., Zomerdijk, Timo P. L., van de Pouw‐Kraan, Tineke, Ottenhoff, Tom H. M., Nibbering, Peter H. · 1996 · European Journal of Immunology

Abstract

Type 2 cytokines are thought to have a protective role in psoriasis vulgaris by dampening the activity of T helper 1 (Th1) lymphocytes. The aim of the present study was to determine the effect of monomethylfumarate (MMF), the most active metabolite of the new anti‐psoriatic drug Fumaderm®, on the production of cytokines and the development of Th subsets. MMF was found to enhance interleukin (IL)‐4 and IL‐5 production by CD2/CD8 monoclonal antibody‐stimulated peripheral blood mononuclear cells (PBMC) in a dose‐dependent manner. Maximal effects of MMF were found at a concentration of 200 μM and resulted in tenfold enhanced levels of IL‐4 and IL‐5 production. MMF did not affect the levels of IL‐2 production, interferon (IFN)‐γ production or proliferative T cell responses in these cultures. Similar effects of MMF were observed in cultures of purified peripheral blood T cells indicating that this compound can act directly on T cells. MMF did not influence cytokine production by purified CD4+CD45RA+ (unprimed) T cells, but greatly enhanced IL‐4 and IL‐5 production without affecting IFN‐γ production by purified CD4+CD45R0+ (primed) T cells. Furthermore, MMF also augmented IL‐4 and IL‐5 production in established Th1/Th0 clones that were stimulated with CD2/CD28 monoclonal antibody. Finally, when PBMC were challenged with Mycobacterium tuberculosis that typically induces Th1 recall responses with strong IFN‐γ secretion, MMF again appeared to induce high levels of IL‐4 and IL‐5 secretion while IFN‐γ production was unaffected. These results may be relevant for the development of therapeutic regimens designed to correct inappropriate Th1 subset development in immunopathologic conditions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/eji.1830260916

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 226

Metadata

Authors
de Jong, R., Bezemer, A. C., Zomerdijk, T. P. L., van de Pouw‐Kraan, T., Ottenhoff, T. H. M., & Nibbering, P. H.
Venue
European Journal of Immunology
Publisher
Wiley
Published
1996-09
Volume
26
Issue
9
Pages
2067-2074
ISSN
  • 0014-2980 (ISSN-L)
  • 1521-4141
OpenAlex
W2030830834
Cited by
226
References
1
FWCI
1.59
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selective stimulation of T helper 2 cytokine responses by the anti‐psoriasis agent monomethylfumarate. https://app.cochat.ai/papers/10.1002/eji.1830260916
The paper
de Jong, R., Bezemer, A. C., Zomerdijk, T. P. L., van de Pouw‐Kraan, T., Ottenhoff, T. H. M., & Nibbering, P. H. (1996). Selective stimulation of T helper 2 cytokine responses by the anti‐psoriasis agent monomethylfumarate. European Journal of Immunology. https://doi.org/10.1002/eji.1830260916

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.